Glucosamine enhances body weight gain and reduces insulin response in mice fed chow diet but mitigates obesity, insulin resistance and impaired glucose tolerance in mice high-fat diet

Metabolism: Clinical and Experimental

Volumn 64, Issue 3, 2015, Pages 368-379

  Hwang, Ji Sun ^a   Park, Ji Won ^b   Nam, Moon Suk ^a   Cho, Hyeongjin ^b   Han, Inn Oc ^a  

^a Inha University School of Medicine   (South Korea)

^b Inha University   (South Korea)

Author keywords

Glucosamine; Insulin resistance; Obesity

Indexed keywords

CHOLESTEROL; DEOXYGLUCOSE; FATTY ACID; GLUCOSAMINE; GLUCOSE; INSULIN; NUCLEOCYTOPLASMIC TRANSPORT PROTEIN; PROTEIN KINASE B; STRESS ACTIVATED PROTEIN KINASE; FAT INTAKE;

3T3 CELL LINE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME PHOSPHORYLATION; FAT MASS; FATTY ACID BLOOD LEVEL; GLUCOSE TOLERANCE TEST; HEPG2 CELL LINE; HUMAN; HUMAN CELL; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; INSULIN RESPONSE; INSULIN SENSITIVITY; INSULIN TOLERANCE TEST; LIPID DIET; MALE; METABOLIC REGULATION; MOUSE; NONHUMAN; NUTRIENT AVAILABILITY; OBESITY; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; WEIGHT GAIN; WESTERN BLOTTING; WHITE ADIPOSE TISSUE; ADVERSE EFFECTS; ANIMAL; C57BL MOUSE; DIET; DRUG EFFECTS; FAT INTAKE; GLUCOSE INTOLERANCE; METABOLISM; ORGAN SIZE; TUMOR CELL LINE;

3T3-L1 CELLS; ANIMALS; CELL LINE, TUMOR; DIET; DIET, HIGH-FAT; DIETARY FATS; GLUCOSAMINE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN RESISTANCE; MALE; MICE; MICE, INBRED C57BL; OBESITY; ORGAN SIZE; WEIGHT GAIN;

EID: 84921733225     PISSN: 00260495     EISSN: 15328600     Source Type: Journal    
DOI: 10.1016/j.metabol.2014.11.005     Document Type: Article

References (41)

1. E.D. Crook, M.C. Daniels, T.M. Smith, and D.A. McClain Regulation of insulin-stimulated glycogen synthase activity by overexpression of glutamine: fructose-6-phosphate amidotransferase in rat-1 fibroblasts Diabetes 42 1993 1289 1296
2. D.A. McClain, and E.D. Crook Hexosamines and insulin resistance Diabetes 45 1996 1003 1009
3. L. Rossetti, M. Hawkins, W. Chen, J. Gindi, and N. Barzilai In vivo glucosamine infusion induces insulin resistance in normoglycemic but not in hyperglycemic conscious rats J Clin Invest 96 1995 132 140
4. A. Giaccari, L. Morviducci, D. Zorretta, P. Sbraccia, F. Leonetti, and S. Caiola In vivo effects of glucosamine on insulin secretion and insulin sensitivity in the rat: possible relevance to the maladaptive responses to chronic hyperglycaemia Diabetologia 38 1995 518 524
5. L. Rossetti Perspective: Hexosamines and nutrient sensing Endocrinology 141 2000 1922 1925
6. M. Hawkins, N. Barzilai, R. Liu, M. Hu, W. Chen, and L. Rossetti Role of the glucosamine pathway in fat-induced insulin resistance J Clin Invest 99 1997 2173 2182
7. J.A. Marshall, R.F. Hamman, and J. Baxter High-fat, low-carbohydrate diet and the etiology of non-insulin-dependent diabetes mellitus: the San Luis Valley Diabetes Study Am J Epidemiol 134 1991 590 603
8. D.A. McClain Hexosamines as mediators of nutrient sensing and regulation in diabetes J Diabetes Complications 16 2002 72 80
9. M. Wierzbicki, A. Chabowski, M. Zendzian-Piotrowska, E. Harasim, and J. Gorski Chronic, in vivo, PPARalpha activation prevents lipid overload in rat liver induced by high fat feeding Adv Med Sci 54 2009 59 65
10. A. Chabowski, M. Zendzian-Piotrowska, K. Konstantynowicz, W. Pankiewicz, A. Miklosz, and B. Lukaszuk Fatty acid transporters involved in the palmitate and oleate induced insulin resistance in primary rat hepatocytes Acta Physiol (Oxf) 207 2013 346 357
11. T.F. Franke, S.I. Yang, T.O. Chan, K. Datta, A. Kazlauskas, and D.K. Morrison The protein kinase encoded by the Akt proto-oncogene is a target of the PDGF-activated phosphatidylinositol 3-kinase Cell 81 1995 727 736
12. B.M. Burgering, and P.J. Coffer Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction Nature 376 1995 599 602
13. E.S. Kandel, and N. Hay The regulation and activities of the multifunctional serine/threonine kinase Akt/PKB Exp Cell Res 253 1999 210 229
14. J.E. Pessin, and A.R. Saltiel Signaling pathways in insulin action: molecular targets of insulin resistance J Clin Invest 106 2000 165 169
15. J.P. McClung, C.A. Roneker, W. Mu, D.J. Lisk, P. Langlais, and F. Liu Development of insulin resistance and obesity in mice overexpressing cellular glutathione peroxidase Proc Natl Acad Sci U S A 101 2004 8852 8857
16. C. Taghibiglou, F. Rashid-Kolvear, S.C. Van Iderstine, H. Le-Tien, I.G. Fantus, and G.F. Lewis Hepatic very low density lipoprotein-ApoB overproduction is associated with attenuated hepatic insulin signaling and overexpression of protein-tyrosine phosphatase 1B in a fructose-fed hamster model of insulin resistance J Biol Chem 277 2002 793 803
17. M.I. Rauchman, J.C. Wasserman, D.M. Cohen, D.L. Perkins, S.C. Hebert, and E. Milford Expression of GLUT-2 cDNA in human B lymphocytes: analysis of glucose transport using flow cytometry Biochim Biophys Acta 1111 1992 231 238
18. A.D. Baron, J.S. Zhu, J.H. Zhu, H. Weldon, L. Maianu, and W.T. Garvey Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity J Clin Invest 96 1995 2792 2801
19. D.C. Love, and J.A. Hanover The hexosamine signaling pathway: deciphering the "O-GlcNAc code" Sci STKE 2005 re13
20. R.R. Traxinger, and S. Marshall Coordinated regulation of glutamine:fructose-6-phosphate amidotransferase activity by insulin, glucose, and glutamine. Role of hexosamine biosynthesis in enzyme regulation J Biol Chem 266 1991 10148 10154
21. B. Luo, G.J. Parker, R.C. Cooksey, Y. Soesanto, M. Evans, and D. Jones Chronic hexosamine flux stimulates fatty acid oxidation by activating AMP-activated protein kinase in adipocytes J Biol Chem 282 2007 7172 7180
22. G.J. Parker, K.C. Lund, R.P. Taylor, and D.A. McClain Insulin resistance of glycogen synthase mediated by o-linked N-acetylglucosamine J Biol Chem 278 2003 10022 10027
23. H. Yki-Jarvinen, A. Virkamaki, M.C. Daniels, D. McClain, and W.K. Gottschalk Insulin and glucosamine infusions increase O-linked N-acetyl-glucosamine in skeletal muscle proteins in vivo Metabolism 47 1998 449 455
24. S.A. Whelan, W.B. Dias, L. Thiruneelakantapillai, M.D. Lane, and G.W. Hart Regulation of insulin receptor substrate 1 (IRS-1)/AKT kinase-mediated insulin signaling by O-Linked beta-N-acetylglucosamine in 3 T3-L1 adipocytes J Biol Chem 285 2010 5204 5211
25. K. Vosseller, L. Wells, M.D. Lane, and G.W. Hart Elevated nucleocytoplasmic glycosylation by O-GlcNAc results in insulin resistance associated with defects in Akt activation in 3 T3-L1 adipocytes Proc Natl Acad Sci U S A 99 2002 5313 5318
26. R.S. Haltiwanger, K. Grove, and G.A. Philipsberg Modulation of O-linked N-acetylglucosamine levels on nuclear and cytoplasmic proteins in vivo using the peptide O-GlcNAc-beta-N-acetylglucosaminidase inhibitor O-(2-acetamido-2-deoxy-D-glucopyranosylidene)amino-N-phenylcarbamate J Biol Chem 273 1998 3611 3617
27. M.G. Buse Hexosamines, insulin resistance, and the complications of diabetes: current status Am J Physiol Endocrinol Metab 290 2006 E1 E8
28. J.C. Fraulob, R. Ogg-Diamantino, C. Fernandes-Santos, M.B. Aguila, and C.A. Mandarim-de-Lacerda A Mouse Model of Metabolic Syndrome: Insulin Resistance, Fatty Liver and Non-Alcoholic Fatty Pancreas Disease (NAFPD) in C57BL/6 Mice Fed a High Fat Diet J Clin Biochem Nutr 46 2010 212 223
29. S. Shrestha, B.R. Bhattarai, K.H. Lee, and H. Cho Mono- and disalicylic acid derivatives: PTP1B inhibitors as potential anti-obesity drugs Bioorg Med Chem 15 2007 6535 6548
30. S.M. Reilly, S.H. Chiang, S.J. Decker, L. Chang, M. Uhm, and M.J. Larsen An inhibitor of the protein kinases TBK1 and IKK-varepsilon improves obesity-related metabolic dysfunctions in mice Nat Med 19 2013 313 321
31. J. Monsenego, A. Mansouri, M. Akkaoui, V. Lenoir, C. Esnous, and V. Fauveau Enhancing liver mitochondrial fatty acid oxidation capacity in obese mice improves insulin sensitivity independently of hepatic steatosis J Hepatol 56 2012 632 639
32. X. Wu, H. Motoshima, K. Mahadev, T.J. Stalker, R. Scalia, and B.J. Goldstein Involvement of AMP-activated protein kinase in glucose uptake stimulated by the globular domain of adiponectin in primary rat adipocytes Diabetes 52 2003 1355 1363
33. Y. Nakatani, H. Kaneto, D. Kawamori, M. Hatazaki, T. Miyatsuka, and T.A. Matsuoka Modulation of the JNK pathway in liver affects insulin resistance status J Biol Chem 279 2004 45803 45809
34. R.C. Cooksey, and D.A. McClain Increased hexosamine pathway flux and high fat feeding are not additive in inducing insulin resistance: evidence for a shared pathway Amino Acids 40 2011 841 846
35. C. Barrientos, R. Racotta, and L. Quevedo Glucosamine attenuates increases of intraabdominal fat, serum leptin levels, and insulin resistance induced by a high-fat diet in rats Nutr Res 30 2010 791 800
36. J. Hirosumi, G. Tuncman, L. Chang, C.Z. Gorgun, K.T. Uysal, and K. Maeda A central role for JNK in obesity and insulin resistance Nature 420 2002 333 336
37. G. Solinas, C. Vilcu, J.G. Neels, G.K. Bandyopadhyay, J.L. Luo, and W. Naugler JNK1 in hematopoietically derived cells contributes to diet-induced inflammation and insulin resistance without affecting obesity Cell Metab 6 2007 386 397
38. Y.L. Wu, A.H. Lin, C.H. Chen, W.C. Huang, H.Y. Wang, and M.H. Liu Glucosamine attenuates cigarette smoke-induced lung inflammation by inhibiting ROS-sensitive inflammatory signaling Free Radic Biol Med 69 2014 208 218
39. S.Y. Hwang, J.S. Hwang, S.Y. Kim, and I.O. Han Glucosamine inhibits lipopolysaccharide-stimulated inducible nitric oxide synthase induction by inhibiting expression of NF-kappaB/Rel proteins at the mRNA and protein levels Nitric Oxide 31 2013 1 8
40. S.Y. Hwang, J.H. Shin, J.S. Hwang, S.Y. Kim, J.A. Shin, and E.S. Oh Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury Glia 58 2010 1881 1892
41. A. Aghazadeh-Habashi, S. Sattari, F. Pasutto, and F. Jamali Single dose pharmacokinetics and bioavailability of glucosamine in the rat J Pharm Pharm Sci 5 2002 181 184